Canopy Rivers, the corporate venturing unit spun out of cannabis grower Canopy Growth, has gone public through a reverse merger.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

Technion’s robotic surgery business Mazor Robotics has been snapped up by medical device developer Medtronic, which had already invested $72m in the company.

Bristol microscopy technology spinout NuNano has secured cash from the university’s Enterprise Fund for a second time.

Stanford-StartX Fund is among medical device developer Madorra’s backers, along with Fogarty Institute of Innovation and OneVentures Healthcare.

The Parkwalk-managed University of Bristol Enterprise Fund has joined parent IP Group to become an investor in macular degeneration-focused spinout Exonate.

Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.

The Forbes-backed end-to-end healthcare product supplier has raised $88m in series A funding and added a smoking cessation service.

Nationwide Children’s Hospital spinout Celenex could fetch as much as $452m upon completion of milestones after progressing rare disease therapies conceived at the hospital’s collaborative program with Ohio State University.

The immuno-oncology therapy developer's investors include UC’s office of the chief investment officer, which contributed to a $300m round in January.